Proof of Concept of the Contribution of the Interaction between Trait-like and State-like Effects in Identifying Individual-Specific Mechanisms of Action in Biological Psychiatry.
Proof of Concept of the Contribution of the Interaction between Trait-like and State-like Effects in Identifying Individual-Specific Mechanisms of Action in Biological Psychiatry.
复制标题
在生物精神病学中识别个体特异性作用机制时,类特质和类状态效应之间的相互作用的贡献的概念证明。
DOI:
10.3390/jpm12081197
复制
发表时间:
2022-07-23
影响因子:
--
通讯作者:
Rutherford, Bret R.
中科院分区:
文献类型:
--
作者:
Zilcha-Mano, Sigal;Solomonov, Nili;Posner, Jonathan E.;Roose, Steven P.;Rutherford, Bret R.
关键词:
Background: Identifying individual-specific mechanisms of action may facilitate progress toward precision medicine. Most studies seeking to identify mechanisms of action collapse together two distinct components: pre-treatment trait-like characteristics differentiating between individuals and state-like characteristics changing within each individual over the course of treatment. We suggest a conceptual framework highlighting the importance of studying interactions between trait-like and state-like components in the development of moderated mediation models that can guide personalized targeted interventions. Methods: To facilitate implementation of this framework, two empirical demonstrations are presented from a recent clinical trial and neuroimaging study. The first examines limbic reactivity during an emotional face task; the second concerns striatal activation in a monetary reward task. Results: In both tasks, considering the interaction between trait-like and state-like components predicted treatment outcome more robustly than did the trait-like or state-like components examined individually. Conclusions: These findings suggest that the extent to which state-like modulation of neural activations can serve as a potential treatment target depends on the pre-treatment, trait-like levels of activation in these regions. Thus, the interaction between trait-like and state-like components can serve as a promising path to the development of personalized interventions within a precision medicine framework in which mechanisms of action are individual-specific.
登录
查看更多内容
影响因子:
2.5
作者:
Fluckiger, Christoph;Del Re, A. C.;Horvath, Adam O.
通讯作者:
Horvath, Adam O.
影响因子:
10.6
作者:
Pizzagalli, DA;Jahn, AL;O'Shea, JP
通讯作者:
O'Shea, JP
影响因子:
3.4
作者:
Patel, Kruti D.;Suhr, Julie A.
通讯作者:
Suhr, Julie A.
影响因子:
5.9
作者:
Accurso, Erin C.;Fitzsimmons-Craft, Ellen E.;Peterson, Carol B.
通讯作者:
Peterson, Carol B.
影响因子:
3.8
作者:
Selya AS;Rose JS;Dierker LC;Hedeker D;Mermelstein RJ
通讯作者:
Mermelstein RJ